Anlet 75 mg (Tablet)
Unit Price: ৳ 11.00 (3 x 10: ৳ 330.00)
Strip Price: ৳ 110.00
Medicine Details
Category | Details |
---|---|
Generic | Clopidogrel bisulphate |
Company | Globe pharmaceuticals ltd |
Indications
- Reduction of myocardial infarction (MI) rate
- Reduction of stroke rate
- Treatment for non-ST-segment elevation ACS
- Treatment for unstable angina (UA)
- Treatment for non-ST-elevation myocardial infarction (NSTEMI)
- Treatment for acute ST-elevation myocardial infarction (STEMI)
- Prevention of recent MI
- Prevention of recent stroke
- Prevention of peripheral arterial disease
- Reduction of bleeding risk
- Antiplatelet effect
Pharmacology
- Prodrug
- Inhibition of platelet activation
- Irreversible binding to P2Y12 receptors
- Dose-dependent inhibition of platelet aggregation
- Onset of action within 2 hours
- Steady state inhibition between Day 3 and Day 7
Dosage & Administration
- Loading dose of 300 mg (4 tablets)
- Maintenance dose of 75 mg once daily
- Oral administration
- Fast antiplatelet effect when initiated with a loading dose
Interaction
- Increased risk of bleeding with NSAIDs, warfarin, SSRIs, SNRIs
- Avoid concomitant use with CYP2C19 inhibitors like omeprazole or esomeprazole
- Increased plasma concentrations of Repaglinide when used concomitantly
Contraindications
- Hypersensitivity to the drug substance or any component
- Active pathological bleeding such as peptic ulcer or intracranial hemorrhage
Side Effects
- Common: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions
- Rare: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders
Pregnancy & Lactation
- Use during pregnancy only if clearly needed
- Unknown excretion in human breast milk
- Decision making for breastfeeding mothers
Precautions & Warnings
- Metabolism impairment in CYP2C19 poor metabolizer
- Risk of bleeding due to lifelong platelet aggregation inhibition
- Increased risk of cardiovascular events after discontinuation
- Reported cases of Thrombotic Thrombocytopenic Purpura (TTP)
- Reported cases of hypersensitivity reactions
Use in Special Populations
- Safety and effectiveness not established in pediatric populations
- No dosage adjustment necessary in elderly patients
Overdose Effects
- May lead to bleeding complications
- Potential restoration of clotting ability with platelet transfusion
Therapeutic Class
- Anti-platelet drugs
Storage Conditions
- Keep below 30°C temperature
- Store in a dry place
- Protected from light
- Avoid freezing
- Keep out of reach of children